Gene: LRRIQ1
Official Full Name: leucine rich repeats and IQ motif containing 1provided by HGNC
Gene Summary: Predicted to be involved in regulation of signal transduction. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25183 | LRRIQ1 Knockout cell line (HeLa) | Human | LRRIQ1 | 1:3~1:6 | Negative | Online Inquiry |
KO25184 | LRRIQ1 Knockout cell line (HCT 116) | Human | LRRIQ1 | 1:2~1:4 | Negative | Online Inquiry |
KO25185 | LRRIQ1 Knockout cell line (HEK293) | Human | LRRIQ1 | 1:3~1:6 | Negative | Online Inquiry |
KO25186 | LRRIQ1 Knockout cell line (A549) | Human | LRRIQ1 | 1:3~1:4 | Negative | Online Inquiry |
LRRIQ1 Gene Knockout Cell Lines are expertly developed cellular models designed to facilitate the study of the LRRIQ1 gene's role in various biological processes. This product is achieved through a precise gene-editing technique, typically CRISPR-Cas9, which enables the targeted disruption of the LRRIQ1 gene. By eliminating the expression of this specific gene, researchers can assess its functions and contributions to cellular behavior, signaling pathways, and developmental processes.
The primary function of these knockout cell lines is to provide a robust platform for investigating the physiological and pathological implications of LRRIQ1 deficiency. They enable researchers to observe changes in cellular morphology, growth patterns, and responses to environmental stimuli, thus shedding light on the gene’s involvement in diseases such as cancer, neurodegeneration, and genetic disorders. The ability to create stable cell lines that lack LRRIQ1 expression offers a unique opportunity to elucidate the downstream effects and compensatory mechanisms that may arise from its loss.
The scientific significance of LRRIQ1 Gene Knockout Cell Lines extends beyond basic research; they serve as invaluable tools for drug discovery and validation. By using these models, scientists can identify potential therapeutic targets and evaluate drug efficacy in contexts where the LRRIQ1 gene is implicated.
In comparison to other genetic manipulation techniques, our knockout cell lines offer superior reliability and reproducibility. They allow for more straightforward experiments in both in vitro and in vivo applications with minimal background noise from off-target effects. Additionally, the user-friendly nature of these cell lines supports faster experimental throughput, significantly accelerating research timelines.
For researchers and clinicians focused on understanding the molecular mechanisms behind cellular function and disease, LRRIQ1 Gene Knockout Cell Lines represent a powerful and essential resource. Our team brings extensive expertise in genetic engineering and cell line development, ensuring that our products meet the highest standards for quality and performance. Trust us to support your research endeavors with innovative biological tools that contribute to advancing scientific knowledge and therapeutic innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.